eHealth Inc Dossier
|
SectorFinancials IndustryInsurance Brokers Beta (adjusted)1.36 Intrinsic Value $9.26median of 2 methodsbased on filings through 30 Jun 2026 Market Price $0.71Price as of 30 Sep 2026 Significantly undervaluedIntrinsic value is 1205% above the market price −50% · IV below pricenear fair value ±15%IV above price · +50% marker beyond scale (+1,205%) Data confidence Sign in to view data confidence Market Cap $22.5M Enterprise Value $136.6M Shares Outstanding 31.7M diluted Next Earnings Date4 Nov 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary eHealth, Inc. is undergoing a major strategic transformation, characterizing fiscal year 2026 as an intentional 'bridge year' focused on margin optimization, cost reduction, and cash flow generation over enrollment volume. While the company is on track to reduce annual operating costs by $90 million and has expanded its Medicare segment gross margin, it faces significant top-line headwinds with Q1 2026 revenue declining 22% year-over-year. Given the near-term revenue visibility risks and the transition to its new Lifetime Advisory Model, a Hold recommendation is warranted until clear signs of growth resumption emerge in 2027. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$1.50 Mean target$2.06 High · most bullish analyst$3.00 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $1.2020% The bear case is driven by persistent top-line contraction, higher-than-expected customer churn during enrollment periods, and further compression of Medicare Advantage Lifetime Value (MA LTV). If the deliberate pullback in marketing spend leads to a permanent loss of market share to competitors like GoHealth, or if regulatory changes pressure Medicare commissions, the company may fail to achieve its 2027 growth targets. Base CaseCentral scenario $2.5050% The base case assumes eHealth performs within its guided 2026 ranges (revenue of $405M–$445M, GAAP net income of $8M–$25M, and adjusted EBITDA of $55M–$75M). The stock is expected to trade sideways as the market monitors the transition from transactional enrollment to relationship-based lifetime advisory, waiting for validated improvements in member persistency and ancillary product attachment rates. Bull CaseUpside scenario $3.0030% The bull case relies on the successful execution of the Lifetime Advisory Model and cost-rationalization efforts. If eHealth successfully reduces fixed operating costs by $30 million in 2026 and achieves its target of break-even operating cash flow, the streamlined cost structure will drive significant operating leverage. Resuming mid-single digit revenue growth in 2027 and reaching a 20% adjusted EBITDA margin by 2028 would trigger a substantial upward revaluation. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |